Table 4.
Frequency of AD-related comorbidities among mild-to-moderate AD patients and matched non-AD controls in THIN
| Comorbidities | Mild-to-moderate AD n (%) |
Matched non-AD control n (%) |
|---|---|---|
| Asthma | 3757 (11.13%) | 1801 (5.34%) |
| Smoking | 2260 (6.70%) | 2774 (8.22%) |
| Skin infections | 2218 (6.57%) | 508 (1.51%) |
| Depression | 1093 (3.24%) | 582 (1.72%) |
| Anxiety | 1044 (3.09%) | 395 (1.17%) |
| Allergic rhinitis | 612 (1.81%) | 166 (0.49%) |
| Sleep disorder | 467 (1.38%) | 193 (0.57%) |
| Allergic contact dermatitis | 356 (1.05%) | 31 (0.09%) |
| Ischaemic heart disease | 322 (0.95%) | 177 (0.52%) |
| Obesity | 129 (0.38%) | 54 (0.16%) |
AD patients were propensity score matched with up to three non-AD controls based on demographics including age, sex, socio-economic status and practice ID
AD atopic dermatitis, THIN The Health Improvement Network